NZ186735A - 9-flouroprednisolone derivatives and pharmaceutical compositions - Google Patents

9-flouroprednisolone derivatives and pharmaceutical compositions

Info

Publication number
NZ186735A
NZ186735A NZ186735A NZ18673578A NZ186735A NZ 186735 A NZ186735 A NZ 186735A NZ 186735 A NZ186735 A NZ 186735A NZ 18673578 A NZ18673578 A NZ 18673578A NZ 186735 A NZ186735 A NZ 186735A
Authority
NZ
New Zealand
Prior art keywords
flouroprednisolone
derivatives
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NZ186735A
Other languages
English (en)
Inventor
R Wiechert
H Wendt
K Annen
J-F Kapp
H Laurent
H Hofmeister
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2712862A external-priority patent/DE2712862C2/de
Priority claimed from DE19782809732 external-priority patent/DE2809732C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NZ186735A publication Critical patent/NZ186735A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ186735A 1977-03-21 1978-03-20 9-flouroprednisolone derivatives and pharmaceutical compositions NZ186735A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2712862A DE2712862C2 (de) 1977-03-21 1977-03-21 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19782809732 DE2809732C2 (de) 1978-03-03 1978-03-03 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate, die diese Wirkstoffe enthalten

Publications (1)

Publication Number Publication Date
NZ186735A true NZ186735A (en) 1980-10-24

Family

ID=25771793

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ186735A NZ186735A (en) 1977-03-21 1978-03-20 9-flouroprednisolone derivatives and pharmaceutical compositions

Country Status (20)

Country Link
JP (1) JPS53130651A (fi)
AT (1) AT365203B (fi)
AU (1) AU525614B2 (fi)
CA (1) CA1104124A (fi)
CH (1) CH638226A5 (fi)
CS (1) CS202591B2 (fi)
DD (1) DD134955A5 (fi)
DK (1) DK126378A (fi)
ES (1) ES468107A1 (fi)
FR (1) FR2384792A1 (fi)
GB (1) GB1603281A (fi)
GR (1) GR70385B (fi)
IE (1) IE46584B1 (fi)
IL (1) IL54308A (fi)
IT (1) IT1095477B (fi)
LU (1) LU79271A1 (fi)
NO (1) NO151043C (fi)
NZ (1) NZ186735A (fi)
RO (1) RO81525B (fi)
SE (1) SE431656B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
JPH07213320A (ja) * 1994-02-04 1995-08-15 Daiwa:Kk 長尺物用バック

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride
CH529739A (fr) * 1972-02-28 1972-10-31 Sdc Steroidi Dev Co Procédé pour la préparation d'un stéroïde de la série des prégnadiènes
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids

Also Published As

Publication number Publication date
AU3434678A (en) 1979-09-27
IE46584B1 (en) 1983-07-27
RO81525A (ro) 1983-04-29
AU525614B2 (en) 1982-11-18
JPS6131116B2 (fi) 1986-07-17
GB1603281A (en) 1981-11-25
JPS53130651A (en) 1978-11-14
NO151043B (no) 1984-10-22
CA1104124A (en) 1981-06-30
DD134955A5 (de) 1979-04-04
FR2384792A1 (fr) 1978-10-20
IE780545L (en) 1978-09-21
IL54308A0 (en) 1978-06-15
AT365203B (de) 1981-12-28
LU79271A1 (de) 1978-06-29
SE7803168L (sv) 1978-09-22
DK126378A (da) 1978-09-22
NO780984L (no) 1978-09-22
IT1095477B (it) 1985-08-10
RO81525B (ro) 1983-04-30
ATA195978A (de) 1981-05-15
ES468107A1 (es) 1979-07-01
CS202591B2 (en) 1981-01-30
FR2384792B1 (fi) 1980-04-04
IL54308A (en) 1984-03-30
IT7821364A0 (it) 1978-03-20
NO151043C (no) 1985-01-30
SE431656B (sv) 1984-02-20
GR70385B (fi) 1982-10-05
CH638226A5 (en) 1983-09-15

Similar Documents

Publication Publication Date Title
NZ188320A (en) Thienothiazine derivatives preparation and pharmaceutical compositions
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
NZ189086A (en) Acylanilide derivatives and pharmaceutical and veterinary compositions
NZ188140A (en) Nitroimidazole derivatives and pharmaceutical compositions
NZ189253A (en) Amine derivatives and pharmaceutical compositions
NZ186965A (en) Guanidino derivatives and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
NZ186692A (en) Morphine derivatives and pharmaceutical compositions
NZ186189A (en) M-trifluoromethyl phenylpiderazine derivatives and pharmaceutical compositions
NZ188976A (en) Prostacyclin derivatives and pharmaceutical compositions
NZ187272A (en) Alkylenediamine derivatives and pharmaceutical compositions
DE2862107D1 (en) Glucosamine-peptide derivatives and their pharmaceutical compositions
NZ188521A (en) Tetrapeptide derivatives and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
NZ188038A (en) Di-orthosubstituted benzene derivatives and pharmaceutical compositions
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
NZ186693A (en) Morphine derivatives and pharmaceutical compositions
NZ186335A (en) Oxadizolopyrimidine derivatives and pharmazeutical compositions
NZ187876A (en) Tetraline derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ187020A (en) Isoindoline derivatives and pharmaceutical compositions